Hospira Inc (HSP) 89.95 $HSP
Correction: Execution Drugs-Pfizer story
By The Associated Press - AP - Sat May 14, 12:25PM CDT
In a story May 13 about a pharmaceutical company's refusal to sell states drugs used in lethal injections, The Associated Press erroneously spelled the last name of the director for Reprieve, a civil rights group opposed to the death penalty. Her name is Maya Foa, not Maya Foia.
PFE: 36.39 (-0.92), HSP: 89.95 (-0.01)
Pfizer says it's blocking use of drugs for lethal injections
By ANDREW WELSH-HUGGINS - AP - Sat May 14, 11:58AM CDT
Pharmaceutical company Pfizer said Friday it was blocking use of its drugs in lethal injections, which means all federally approved drugmakers whose medications could be used for executions have now put them off limits.
PFE: 36.39 (-0.92), HSP: 89.95 (-0.01)
Merger & Acquisition ETFs: Will 2016 Replicate 2015?
Zacks Equity Research - Zacks Investment Research - Tue Dec 15, 11:50AM CST
ETFs to play the winning momentum of merger and acquisitions in 2015 globally.
PCYC: 261.25 (+1.70), BRCM: 54.67 (+0.17), PFE: 36.39 (-0.92), ABBV: 66.78 (-0.16), MNA: 28.39 (-0.13), NXPI: 81.85 (-2.38), FSL: 36.53 (-1.53), HSP: 89.95 (-0.01), AVGO: 162.89 (-0.62), CSMA: 20.50 (+1.27), MRGR: 36.03 (-0.12)
Hospira Up 73.5% Since SmarTrend Uptrend Call (HSP)
Comtex SmarTrend(R) - Thu Nov 19, 5:58PM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 13 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
Hospira Shares Up 73.5% Since SmarTrend's Buy Recommendation (HSP)
Comtex SmarTrend(R) - Thu Nov 05, 10:29AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 13 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
Uptrend Call Working As Hospira Stock Rises 73.5% (HSP)
Comtex SmarTrend(R) - Thu Nov 05, 10:25AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 13 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
Kansas pharmaceutical plant settles discrimination complaint
The Hutchinson (Kan.) News - Wed Oct 14, 2:33PM CDT
MCPHERSON, Kan. (AP) — A central Kansas pharmaceutical plant accused of gender discrimination must pay about $400,000 in back wages and hire more women, according to a federal settlement.
PFE: 36.39 (-0.92), HSP: 89.95 (-0.01)
Hospira Has Returned 73.5% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - Wed Oct 14, 9:58AM CDT
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 12 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
73.5% Return Seen to Date on SmarTrend Hospira Call (HSP)
Comtex SmarTrend(R) - Tue Sep 29, 4:51PM CDT
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 11 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
State Street Global Advisors Announces Impact of Receiving Settlement Payment
BusinessWire - Thu Sep 24, 4:33PM CDT
The SPDR(R) Exchange Traded Fund (ETF) listed in the table below, announced today that the Fund received a payment as an authorized claimant from a class action settlement related to Hospira, Inc. (NYSE: HSP).
STT: 65.33 (-0.61), HSP: 89.95 (-0.01)
India-based company doesn't want drug used for executions
By CLAUDIA LAUER - AP - Tue Sep 22, 4:27PM CDT
LITTLE ROCK, Ark. (AP) — An India-based company that appears to have made a drug that Arkansas purchased for lethal injections says it doesn't want its products used in the state's plans.
HSP: 89.95 (-0.01)
APNewsBreak: Arkansas execution plan may use UK firm's drug
By CLAUDIA LAUER - AP - Fri Sep 18, 12:39PM CDT
LITTLE ROCK, Ark. (AP) — A British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine if the state plans to use them anyway, but prison officials are dismissing inquiries about the drug by citing a new law that makes all execution policies an official state secret.
HSP: 89.95 (-0.01)
Correction: Execution Drugs-Pfizer story
By The Associated Press - AP - Sat May 14, 12:25PM CDT
In a story May 13 about a pharmaceutical company's refusal to sell states drugs used in lethal injections, The Associated Press erroneously spelled the last name of the director for Reprieve, a civil rights group opposed to the death penalty. Her name is Maya Foa, not Maya Foia.
PFE: 36.39 (-0.92), HSP: 89.95 (-0.01)
Pfizer says it's blocking use of drugs for lethal injections
By ANDREW WELSH-HUGGINS - AP - Sat May 14, 11:58AM CDT
Pharmaceutical company Pfizer said Friday it was blocking use of its drugs in lethal injections, which means all federally approved drugmakers whose medications could be used for executions have now put them off limits.
PFE: 36.39 (-0.92), HSP: 89.95 (-0.01)
Merger & Acquisition ETFs: Will 2016 Replicate 2015?
Zacks Equity Research - Zacks Investment Research - Tue Dec 15, 11:50AM CST
ETFs to play the winning momentum of merger and acquisitions in 2015 globally.
PCYC: 261.25 (+1.70), BRCM: 54.67 (+0.17), PFE: 36.39 (-0.92), ABBV: 66.78 (-0.16), MNA: 28.39 (-0.13), NXPI: 81.85 (-2.38), FSL: 36.53 (-1.53), HSP: 89.95 (-0.01), AVGO: 162.89 (-0.62), CSMA: 20.50 (+1.27), MRGR: 36.03 (-0.12)
Hospira Up 73.5% Since SmarTrend Uptrend Call (HSP)
Comtex SmarTrend(R) - Thu Nov 19, 5:58PM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 13 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
Hospira Shares Up 73.5% Since SmarTrend's Buy Recommendation (HSP)
Comtex SmarTrend(R) - Thu Nov 05, 10:29AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 13 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
Uptrend Call Working As Hospira Stock Rises 73.5% (HSP)
Comtex SmarTrend(R) - Thu Nov 05, 10:25AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 13 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
Kansas pharmaceutical plant settles discrimination complaint
The Hutchinson (Kan.) News - Wed Oct 14, 2:33PM CDT
MCPHERSON, Kan. (AP) — A central Kansas pharmaceutical plant accused of gender discrimination must pay about $400,000 in back wages and hire more women, according to a federal settlement.
PFE: 36.39 (-0.92), HSP: 89.95 (-0.01)
Hospira Has Returned 73.5% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - Wed Oct 14, 9:58AM CDT
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 12 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
73.5% Return Seen to Date on SmarTrend Hospira Call (HSP)
Comtex SmarTrend(R) - Tue Sep 29, 4:51PM CDT
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 11 months, Hospira has returned 73.51% as of today's recent price of $89.95.
HSP: 89.95 (-0.01)
State Street Global Advisors Announces Impact of Receiving Settlement Payment
BusinessWire - Thu Sep 24, 4:33PM CDT
The SPDR(R) Exchange Traded Fund (ETF) listed in the table below, announced today that the Fund received a payment as an authorized claimant from a class action settlement related to Hospira, Inc. (NYSE: HSP).
STT: 65.33 (-0.61), HSP: 89.95 (-0.01)
India-based company doesn't want drug used for executions
By CLAUDIA LAUER - AP - Tue Sep 22, 4:27PM CDT
LITTLE ROCK, Ark. (AP) — An India-based company that appears to have made a drug that Arkansas purchased for lethal injections says it doesn't want its products used in the state's plans.
HSP: 89.95 (-0.01)
APNewsBreak: Arkansas execution plan may use UK firm's drug
By CLAUDIA LAUER - AP - Fri Sep 18, 12:39PM CDT
LITTLE ROCK, Ark. (AP) — A British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine if the state plans to use them anyway, but prison officials are dismissing inquiries about the drug by citing a new law that makes all execution policies an official state secret.
HSP: 89.95 (-0.01)
